Latest Market Strategy News

EVE Health Group has raised $0.9 million to advance its pharmaceutical reformulation programs targeting global markets worth over US$30 billion. The funding will support development of improved delivery technologies for medicines nearing patent expiry.

Locksley Resources has produced 99.5% pure antimony trioxide from its Desert Antimony Mine feedstock, marking a key step toward restoring a fully domestic U.S. supply chain for this critical mineral.

St George Mining has formed a strategic alliance with Brazilian nanotechnology firm Nanum Nanotecnologia to enhance the processing and commercialisation of rare earth elements from its Araxá Project, aiming to upgrade high-value magnet and heavy rare earth concentrations.

Imugene Limited reports striking early results from its Phase 1b azer-cel trial, achieving a 100% overall response rate in chronic lymphocytic leukemia and 80% in marginal zone lymphoma, while broadening its study to include a BTK inhibitor combination.

icetana AI has landed a significant $2.1 million contract renewal and expansion with its largest customer, Middle East retail giant Majid al Futtaim Properties, reinforcing its foothold in large-scale security AI.

Cyclopharm Limited has responded to ASX queries clarifying the material significance of its Technegas® contract with the US National Institutes of Health, while confirming robust progress in expanding its US footprint.

Felix Group Holdings has appointed seasoned tech leader Chris Atkin as CEO, aiming to drive growth and integrate its Nexvia platform. Atkin’s track record in scaling SaaS businesses signals a strategic push for disciplined expansion.

Locksley Resources has reported strong surface assay results from its Desert Antimony Mine in California, confirming continuity of high-grade antimony mineralisation and supporting ongoing drilling efforts.

The Star Entertainment Group reports a $110 million statutory loss for H1 FY26 as it undertakes major operational restructuring and seeks refinancing amid challenging market conditions.

Norwood Systems Limited reported a significant revenue increase for the half-year ended December 2025, alongside a widening net loss and strategic progress with Tier-1 telecom customers. The company secured additional funding and advanced its AI-driven voice platforms in collaboration with global hyperscalers.

CONNEQT Health reported a 40% revenue increase to $2.28 million for the half-year ending December 2025, driven by strong sales of its CONNEQT Pulse device and early subscription uptake. Despite narrowing its net loss by 14%, the company continues to navigate operational restructuring and funding challenges as it pivots towards a recurring revenue model.

De.mem Limited reported a 20% increase in revenue to $29.9 million for FY2025, alongside a reduced net loss and its first full-year positive adjusted EBITDA. The company also completed the acquisition of Core Chemicals, expanding its specialty chemicals footprint in the gold mining sector.